Back to Search
Start Over
Next Generation Immunotherapies Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | GlaxoSmithKline, Roche, Regeneron Pharma, Boehringer
Next Generation Immunotherapies Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | GlaxoSmithKline, Roche, Regeneron Pharma, Boehringer
- Source :
- M2 Presswire. October 12, 2023
- Publication Year :
- 2023
-
Abstract
- M2 PRESSWIRE-October 12, 2023-: Next Generation Immunotherapies Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | GlaxoSmithKline, Roche, Regeneron Pharma, Boehringer (C)1994-2023 M2 COMMUNICATIONS [...]
- Subjects :
- Bristol-Myers Squibb Co. -- Forecasts and trends
Boehringer Ingelheim GmbH -- Forecasts and trends
Regeneron Pharmaceuticals Inc. -- Forecasts and trends
Business -- Research
BCG vaccines -- Forecasts and trends
BCG -- Forecasts and trends
Immunotherapy -- Forecasts and trends
Drug approval -- Forecasts and trends
Epidemiology -- Forecasts and trends
Pharmaceutical industry -- Forecasts and trends
Market trend/market analysis
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.768599963